At‑home autoinjector option offers new flexibility for patients and care partners
Source: PharmaTimes
You may also like
AstraZeneca agrees on $1.5bn deal with Dizal...
Cherry appoints Peter Henshaw as new Managing Director
Novel Epigenetic Therapy Targets Treatment-Resistant...
FDA Issues Proposal to Streamline Registration for...
Cellares and Sonoma Biotherapeutics Agree to Automate...
Genome-Scale CRISPRi Atlas Maps Gene Function Across...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.